Trade

Entero Healthcare Solutions share price

Balanced risk
  • 33%Low risk
  • 33%Moderate risk
  • 33%Balanced risk
  • 33%High risk
  • 33%Extreme risk
  • 996.10(-0.64%)
    December 16, 2025 15:28:28 PM IST
    • NSE
    • BSE
  • Vol : 0.99 K (NSE + BSE)
    Last 20 day avg : 2.12 K

Entero Healthcare Solutions is trading -0.64% lower at Rs 996.10 as compared to its last closing price. Entero Healthcare Solutions has been trading in the price range of 1,005.95 & 990.75. Entero Healthcare Solutions has given -30.04% in this year & -3.62% in the last 5 days. Entero Healthcare Solutions has TTM P/E ratio 43.88 as compared to the sector P/E of 27.08.There are 3 analysts who have initiated coverage on Entero Healthcare Solutions. There are 1 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 31.60 Crores in its last quarter.Listed peers of Entero Healthcare Solutions include Infosys (-0.91%), Tata Consultancy Services (-0.80%), HCL Technologies (-1.90%).The Mutual Fund holding in Entero Healthcare Solutions was at 4.78% in 30 Sep 2025. The MF holding has decreased from the last quarter. The FII holding in Entero Healthcare Solutions was at 14.68% in 30 Sep 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Dec 16, 2025, 10:16 PM UTC

  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.22
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    0.26
    Indicates undervaluation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
Price range
Day Range
Lowest
990.75
Highest
1,005.95
52 week range
Lowest
984.10
Highest
1,564.95
Entero Healthcare Solutions Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Infosys
Bullish
1,592.35-0.916,61,561.6224.806.912.826.02
Tata Consultancy Services
Moderately Bullish
3,204.55-0.8011,59,434.2324.0812.331.928.27
HCL Technologies
Bullish
1,652.15-1.904,48,431.3726.486.453.263.89
LTIMindtree
Bullish
6,229.45-0.671,84,642.0340.468.181.078.13
Tech Mahindra
Bullish
1,573.30-0.141,54,007.8135.275.592.884.19
Mutual Fund Ownership
View all
Invesco India Contra Fund Growth
NA
  • Amount Invested (Cr.) 189.40
  • % of AUM 1.03
Invesco India ELSS Tax Saver Fund Growth
3/5
  • Amount Invested (Cr.) 27.02
  • % of AUM 0.95
HSBC Consumption Fund Regular Growth
NA
  • Amount Invested (Cr.) 12.19
  • % of AUM 0.80
Invesco India Smallcap Fund Regular Growth
3/5
  • Amount Invested (Cr.) 53.43
  • % of AUM 0.78
Invesco India Multicap Fund Growth
2/5
  • Amount Invested (Cr.) 24.02
  • % of AUM 0.60
Entero Healthcare Solutions Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2025-11-12Quarterly Results
2025-08-08Quarterly Results
2025-05-27Audited Results
2025-02-12Quarterly Results
2024-11-12Quarterly Results
About the company Entero Healthcare Solutions
  • IndustrySoftware & Programming
  • ISININE010601016
  • BSE Code544122
  • NSE Code
Entero Healthcare Solutions Limited is an India-based technology-driven and integrated healthcare products distribution company. It offers a range of pharmaceuticals and other healthcare products to approximately 86,200 retail pharmacies and healthcare practitioners (HCPs) across 492 districts in India. Its portfolio includes over 68,900 SKUs from more than 2000 pharma companies. The Company is a supplier to over 3,500 hospitals across India, including corporate hospital chains. It has over a network of 104 warehouses. Its technology solutions include Entero Direct, Entero CRM, Entero ERP, and Teqtic. Its Entero Direct platform is a cloud-based software-as-a-service solution that allows retailers to order their procurement needs. The Entero CRM application is a customer relationship management tool that manages and analyzes its interactions with customers, in order to customer retention and wallet share. It also offers its products through the Aayu Chemist app and Medcords platform.
  • Management Info
  • Prabhat AgrawalChief Executive Officer, Managing Director (Promoter)
  • Sanu KapoorCompliance Officer, Vice President - General Counsel, Company Secretary
  • Prem SethiWhole-Time Director
Entero Healthcare Solutions Share Price FAQs

Entero Healthcare Solutions is trading at 996.10 as on Tue Dec 16 2025 09:58:28. This is -0.64% lower as compared to its previous closing price of 1002.50.

The market capitalization of Entero Healthcare Solutions is 4319.04 Cr as on Tue Dec 16 2025 09:58:28.

The average broker rating on Entero Healthcare Solutions is Buy. The breakup of analyst rating is given below -

  • 1 analysts have given a strong buy rating
  • 1 analysts have given a buy rating
  • 1 analysts have given a hold rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Entero Healthcare Solutions is 1564.95 whereas the 52 wk low is 984.10

Entero Healthcare Solutions can be analyzed on the following key metrics -

  • TTM P/E: 43.88
  • Sector P/E: 27.08
  • Dividend Yield: 0.00%
  • D/E ratio: 0.25

Entero Healthcare Solutions reported a net profit of 94.82 Cr in 2025.

The Mutual Fund Shareholding was 4.78% at the end of 30 Sep 2025.